公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 LABTEST DIAGNOSTICA S/A取消

45 记录

产品持有公司班级有效性
CK-MB LIQUIFORM10009010069LABTEST DIAGNOSTICA S/AIII01/03/2035
QUALITROL CK10009010120LABTEST DIAGNOSTICA S/AIII01/03/2036
SANGUE OCULTO iFOBT10009010177LABTEST DIAGNOSTICA S/AIII28/06/2035
Família Qualitrol Hemostasis10009010317LABTEST DIAGNOSTICA S/AIII21/09/2035
DETECT SARS-CoV-2 RT-PCR10009010357LABTEST DIAGNOSTICA S/AIII27/04/2030
Anti SARS-CoV-2 IgM/IgG Rapid Test10009010360LABTEST DIAGNOSTICA S/AIII08/09/2030
COVID-19 Ag Rapid Test10009010361LABTEST DIAGNOSTICA S/AIII24/09/2030
Anti SARS-CoV-2 IgM/IgG Rapid Test SD10009010364LABTEST DIAGNOSTICA S/AIII12/11/2030
Lab Rapid Dengue IgG/IgM10009010366LABTEST DIAGNOSTICA S/AIII04/01/2031
Covid-19 Ag Rapid Test (Oral Fluid)10009010371LABTEST DIAGNOSTICA S/AIII31/05/2031
COVID-19 & FLU A/B Ag Rapid Test Combo10009010372LABTEST DIAGNOSTICA S/AIII14/06/2031
Anti SARS-CoV-2 & M. pneumoniae IgG/IgM Rapid Test Combo10009010373LABTEST DIAGNOSTICA S/AIII14/06/2031
COVID-19 Ag Rapid Test (Swab Naso/Oro)10009010374LABTEST DIAGNOSTICA S/AIII21/06/2031
Detect SARS-CoV-2 (RT-PCR) Fast10009010377LABTEST DIAGNOSTICA S/AIII16/08/2031
Influenza A/B/H1N1 Ag Rapid Test Combo10009010378LABTEST DIAGNOSTICA S/AIII04/10/2031
MyTest COVID-19 Ag Nasal10009010381LABTEST DIAGNOSTICA S/AIII25/04/2032
TG Reagent Kit10009010392LABTEST DIAGNOSTICA S/AIII24/03/2035
ProGRP Reagent Kit10009010393LABTEST DIAGNOSTICA S/AIII10/02/2035
ß-HCG Reagent Kit10009010398LABTEST DIAGNOSTICA S/AIII10/03/2035
Lab Rapid Dengue NS110009010408LABTEST DIAGNOSTICA S/AIII09/10/2033
AFP Reagent Kit10009010425LABTEST DIAGNOSTICA S/AIII15/01/2034
HE4 Reagent Kit10009010426LABTEST DIAGNOSTICA S/AIII15/01/2034
Ferritin Reagent Kit10009010428LABTEST DIAGNOSTICA S/AIII24/02/2035
Lab Rapid GDH / Toxin A and B10009010460LABTEST DIAGNOSTICA S/AIII16/09/2034
Lab Rapid Strep A10009010461LABTEST DIAGNOSTICA S/AIII16/09/2034

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家